A Phase 4 interventional study of Coronary angiography and revascularization if feasible in Non-ST Elevation Myocardial Infarction (NSTEMI) and Angina, Unstable, sponsored by Sahlgrenska University Hospital. Status unknown at 1 site in Sweden. Open to participants aged 80 Years and older. Per ClinicalTrials.gov, last updated 2014-04-29.
Sponsored by Sahlgrenska University Hospital · Phase 4, Interventional, and Treatment
A multicenter, randomized clinical trial in elderly patients (over 80 years old) with unstable angina pectoris or Non-ST elevation myocardial infarction (NSTEMI).
A total of 200 patients will be randomized to medical treatment (100 patients) or coronary angiography with revascularization if feasible (100 patients). Information regarding prior history, frailty, clinical presentation, in-hospital events, complications, angina, quality of life and mortality will be collected. Follow up time is 1 year.
2,744 studies on the registry are indexed under Myocardial Infarction; 418 are open to participants now.
This study's planned enrollment of 200 is above the median of 148 across 1,595 interventional studies indexed under Myocardial Infarction.
Browse Myocardial Infarction studies →Sahlgrenska University Hospital is the lead sponsor of 259 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Acute coronary syndrome with ischemic symptoms (mainly chest pain) lasting over 10 minutes during the last 72 hours.
AND at least one of the following:
Exclusion criteria:
Optimized medical therapy
Coronary angiography and revascularization if feasible
Procedure: Coronary angiography and revascularization if feasible
Coronary angiography and revascularization with PCI or CABG (coronary artery bypass grafting) if feasible
Also known as: Percutaneous coronary intervention (PCI)
Number of participants with major adverse cardiac and cerebral events (the composite of death, myocardial infarction, urgent revascularisation, recurrent hospitalization due to cardiac reason and stroke).
Time frame: 1 year
Number of participants with major bleeding
Time frame: 1 month
Number of participants with major adverse cardiac or cerebral event
Time frame: 1 month
Number of participants with minor bleeding
Time frame: 1 month
Number of participants with composite of cardiac death or myocardial infarction
Time frame: 1 year
Change from baseline of participants level of quality of life measured with the SF-36 questionnaire at 12 months
Time frame: 1 year
Change from baseline of participants level of angina pectoris at 12 months
Time frame: 12 months
Number of participants dead (all cause mortality)
Time frame: 1 year
This study is status unknown, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital